285 related articles for article (PubMed ID: 24147898)
61. Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis.
Silva NC; Silva S; Sarmento B; Pintado M
Drug Deliv; 2015; 22(7):885-93. PubMed ID: 24266551
[TBL] [Abstract][Full Text] [Related]
62. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
63. Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design.
Auwal SM; Zarei M; Tan CP; Basri M; Saari N
Sci Rep; 2018 Jul; 8(1):10411. PubMed ID: 29991723
[TBL] [Abstract][Full Text] [Related]
64. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
[TBL] [Abstract][Full Text] [Related]
65. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
[TBL] [Abstract][Full Text] [Related]
66. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles.
Cetin M; Aktas Y; Vural I; Capan Y; Dogan LA; Duman M; Dalkara T
Drug Deliv; 2007 Nov; 14(8):525-9. PubMed ID: 18027182
[TBL] [Abstract][Full Text] [Related]
67. Encapsulation of indole-3-carbinol and 3,3'-diindolylmethane in zein/carboxymethyl chitosan nanoparticles with controlled release property and improved stability.
Luo Y; Wang TT; Teng Z; Chen P; Sun J; Wang Q
Food Chem; 2013 Aug; 139(1-4):224-30. PubMed ID: 23561099
[TBL] [Abstract][Full Text] [Related]
68. [Injectable borate glass/chitosan composite as drug carrier for treatment of chronic osteomyelitis].
Zhao C; Wang X; Zhang C; Cui X; Jia W; Huang W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):641-6. PubMed ID: 22792754
[TBL] [Abstract][Full Text] [Related]
69. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
Chakraborty SP; Sahu SK; Mahapatra SK; Santra S; Bal M; Roy S; Pramanik P
Nanotechnology; 2010 Mar; 21(10):105103. PubMed ID: 20154376
[TBL] [Abstract][Full Text] [Related]
70. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
Lin AH; Liu YM; Ping QN
Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
[TBL] [Abstract][Full Text] [Related]
71. Carboxymethyl chitosan-soy protein complex nanoparticles for the encapsulation and controlled release of vitamin D₃.
Teng Z; Luo Y; Wang Q
Food Chem; 2013 Nov; 141(1):524-32. PubMed ID: 23768389
[TBL] [Abstract][Full Text] [Related]
72. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
Krauland AH; Alonso MJ
Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
[TBL] [Abstract][Full Text] [Related]
73. [Preparation of cationic vancomycin hydrochloride multivesicular liposomes and its quality].
Yang D; Xu Y; Li F; Liu H; He X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Apr; 27(4):443-8. PubMed ID: 23757873
[TBL] [Abstract][Full Text] [Related]
74. Preparation and physicochemical properties of chitosan broadleaf holly leaf nanoparticles.
Zhang H; Huang Q; Huang Z; Liu T; Li Y
Int J Pharm; 2015 Feb; 479(1):212-8. PubMed ID: 25528364
[TBL] [Abstract][Full Text] [Related]
75. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
Shahbazi MA; Hamidi M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
[TBL] [Abstract][Full Text] [Related]
76. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
77. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK
Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737
[TBL] [Abstract][Full Text] [Related]
78. Loading of anthocyanins on chitosan nanoparticles influences anthocyanin degradation in gastrointestinal fluids and stability in a beverage.
He B; Ge J; Yue P; Yue X; Fu R; Liang J; Gao X
Food Chem; 2017 Apr; 221():1671-1677. PubMed ID: 27979145
[TBL] [Abstract][Full Text] [Related]
79. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
[TBL] [Abstract][Full Text] [Related]
80. Optimization of production parameters for fabrication of thymol-loaded chitosan nanoparticles.
Çakır MA; Icyer NC; Tornuk F
Int J Biol Macromol; 2020 May; 151():230-238. PubMed ID: 32057871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
